Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/10/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. John Schembri

Wrong John Schembri?

Vice President, Finance and Admin...

Phone: (650) ***-****  HQ Phone
Email: j***@***.com
Global Blood Therapeutics Inc
400 East Jamie Court Suite 101
South San Francisco, California 94080
United States

Company Description: Global Blood Therapeutics, Inc. is a product-focused company building a pipeline of innovative, oral medicines to revolutionize the treatment of chronic blood-based...   more
Background

Employment History

Education

  • B.S. degree , Business Administration
    California Polytechnic State University
22 Total References
Web References
Leadership Team - Global Blood Therapeutics
www.globalbloodtx.com, 12 April 2014 [cached]
John Schembri Vice President, Finance and Administration
John Schembri joined Global Blood Therapeutics as vice president, finance and administration in January 2014. Mr. Schembri has more than 25 years of experience as a finance executive in the biotechnology industry and previously served as chief financial officer of BiPar Sciences, which was acquired by Sanofi-Aventis for $500 million. Prior to that Mr. Schembri led the finance team at Sirna Therapeutics, which was acquired by Merck & Co. for $1.1 billion. He also served a key role in the $2 billion sale and integration of COR Therapeutics to Millennium Pharmaceuticals in 2001.
John ...
www.stempar.com, 1 Feb 2014 [cached]
John Schembri
Vice President and CFO
John Schembri has over 25 years experience as a financial executive in the biotechnology industry and previously served as CFO of BiPar Sciences. Prior to that Mr. Schembri led the Finance team at Sirna Therapeutics, which was acquired by Merck & Co. for $1.1 billion. He also served a key role in the $2 billion sale and integration of COR Therapeutics to Millennium Pharmaceuticals. Mr. Schembri received his B.S. degree in Business Administration from California Polytechnic State University in San Luis Obispo, California.
...
John Schembri
John Schembri / Chief ...
www.biparsciences.com, 14 Mar 2009 [cached]
John Schembri / Chief Financial Officer
Mr. Schembri joined BiPar Sciences in 2007 after more than a decade of service to some of biotechnology's most successful and innovative companies. He was Vice President of Finance and Controller of Sirna Therapeutics Inc. until it was sold in December 2006 to Merck & Co. for $1.1 billion. At Sirna, he managed all financial activities involved in the sale of the company to Merck. Prior to joining Sirna, Mr. Schembri was Director of Finance and Controller at Cell Genesys Inc. He has also held similar positions at Cor Therapeutics Inc. and TelikInc.
John ...
www.sirna.com, 1 Mar 2007 [cached]
John Schembri
Vice President and Controller
John Schembri was appointed Vice President and Controller in March 2006.Prior to joining Sirna Therapeutics, Mr. Schembri served as Director of Finance and Controller for several biotechnology companies, including Cell Genesys, Inc. from 2003 to 2006, COR Therapeutics, Inc. from 1998 until 2002 and Telik, Inc. between 1996 and 1997.Before that, Mr. Schembri held financial management positions with O'Neill, Inc. and The Clorox Company from 1990 until 1996.Mr. Schembri was in the audit practice of Deloitte & Touche from 1983 to 1989.He received a B.S. degree from California Polytechnic State University, San Luis Obispo, California and is a Certified Public Accountant.
BiPar Sciences - About Us - Management Team
www.biparsciences.com, 1 Dec 2008 [cached]
John Schembri Chief Financial Officer Mr. Schembri joined BiPar in 2007 after more than a decade of service to some of biotechnology's most successful and innovative companies. He was Vice President of Finance and Controller of Sirna Therapeutics Inc. until it was sold in December 2006 to Merck & Co. for $1.1 billion. At Sirna, he managed all financial activities involved in the sale of the company to Merck. Prior to joining Sirna, Mr. Schembri was Director of Finance and Controller at Cell Genesys Inc. He has also held similar positions at Cor Therapeutics Inc. and Telik Inc.
Other People with the name "Schembri":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304